enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. AOH1996 - Wikipedia

    en.wikipedia.org/wiki/AOH1996

    AOH1996 was created to target a post-translationally modified isoform of PCNA, termed caPCNA, which is preferentially found in cancer cells. PCNA is crucial in the body for DNA repair, but targeting it is difficult because of its role in healthy cells.

  3. Cancer breakthrough as groundbreaking pill found to ‘kill ...

    www.aol.com/cancer-breakthrough-groundbreaking...

    For premium support please call: 800-290-4726 more ways to reach us

  4. After six years of painful injections, Stephanie Walker has had enough. Every 28 days, she drives an hour to Duke’s Cancer center to get 50 mL slowly injected into her glute muscles.

  5. Sanofi shares drop on trial setback for breast cancer pill - AOL

    www.aol.com/news/sanofi-shares-drop-trial...

    (Reuters) -Sanofi's shares slid 5% on Monday after a drug candidate to fight a common type of breast cancer failed to slow progression of the disease in a clinical trial, knocking confidence in ...

  6. Tamoxifen - Wikipedia

    en.wikipedia.org/wiki/Tamoxifen

    Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. [15] It is also being studied for other types of cancer. [15]

  7. Osimertinib - Wikipedia

    en.wikipedia.org/wiki/Osimertinib

    Osimertinib, sold under the brand name Tagrisso, [6] is a medication used to treat non-small-cell lung carcinomas with specific mutations. [7] [8] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.

  8. Pfizer's Forgotten Cancer Pill Is About to Become Its Next ...

    www.aol.com/news/pfizer-apos-forgotten-cancer...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Larotrectinib - Wikipedia

    en.wikipedia.org/wiki/Larotrectinib

    Larotrectinib, sold under the brand name Vitrakvi, is a medication for the treatment of cancer. [ 1 ] [ 5 ] [ 7 ] It is an inhibitor of tropomyosin kinase receptors TrkA , TrkB , and TrkC . [ 8 ] [ 9 ] [ 10 ] It was discovered by Array BioPharma and licensed to Loxo Oncology in 2013.